Starting a GLP-1 medicine can change your appetite fast. The goal is not to eat as little as possible. The goal is to use that quieter hunger to build a steady eating pattern while protecting hydration, nutrition, muscle, and your stomach.
This guide covers what to do before the first dose and during the first few weeks. It focuses on everyday habits backed by clinical trial reports, product labels for Wegovy and Zepbound, and a 2025 joint nutrition advisory from major obesity and nutrition groups.
It is educational, not a personal treatment plan. Follow your clinician's instructions for your prescription. CoreVials research materials (including retatrutide and tirzepatide listings) are for laboratory research only, not for human or animal use.
Before Your First Dose
A little setup helps:
- Stock easy protein foods (eggs, Greek yogurt, cottage cheese, canned fish, tofu, cooked chicken, protein shakes).
- Keep water and an electrolyte drink option available.
- Plan smaller plates and slower meals.
- Ask your clinician what warning signs matter for you, especially if you have kidney, heart, or stomach issues.
- Know your dose-increase schedule and do not change it on your own.
What to Eat When Your Appetite Drops
Many people feel full quickly. That is expected with medicines like Wegovy (semaglutide) and Zepbound (tirzepatide). Useful habits:
- Eat smaller portions.
- Eat slowly and stop at the first sign of fullness.
- Put protein on the plate first.
- Choose nutrient-dense foods over empty snacks.
- Do not force a huge meal just because the clock says "dinner."
The 2025 joint advisory stresses nutrient adequacy and protecting lean mass while appetite is low. In plain English: eat less overall if that happens, but make the food you do eat count.
Protein and Muscle Preservation
Lower appetite can cut protein intake without you noticing. Over time, that can mean losing muscle along with fat.
Practical steps:
- Include protein at each meal.
- Eat the protein portion first when you get full fast.
- Use foods like eggs, Greek yogurt, cottage cheese, fish, poultry, lean meat, tofu, beans, lentils, or a protein shake when solid food is hard.
- Pair protein with strength training. Protein alone is not enough to fully protect muscle.
Many adults do well aiming for roughly 20 to 30 grams of protein per meal. Exact needs vary by body size, age, activity, and medical conditions (especially kidney disease). Ask your clinician or a registered dietitian for a personal target.
Why Keto Is Not Required
You do not need a ketogenic diet to start semaglutide or tirzepatide. There is no strong evidence that keto is required.
The 2025 nutrition advisory instead points to a balanced, nutrient-dense pattern: vegetables, fruits, whole grains, legumes, lean proteins, nuts, and seeds.
A very strict low-carb diet can make it harder for some people to get enough fiber, fluids, and micronutrients. Lower-carb eating can still be fine for some people (for example, when a clinician uses it for diabetes care). It is a choice, not a rule.
Choosing Useful Carbohydrates
Carbs are not the enemy on a GLP-1. The useful split is quality and portion size.
Often better choices:
- Fruit
- Oats
- Potatoes
- Rice
- Whole-grain bread
- Beans and lentils
- Vegetables
These can support exercise, bowel regularity, and overall nutrition. Large amounts of sugary, greasy, or ultra-processed foods may worsen nausea, reflux, or diarrhea for some people.
Related Research Compounds
CoreVials stocks research materials related to the pathways discussed above. These listings are for laboratory research only, not for human or animal use. No pricing is shown here; open a product page for current options.
Hydration and Electrolytes
Nausea, vomiting, and diarrhea can lead to dehydration. Product labels for Wegovy and Zepbound warn that fluid loss can contribute to kidney injury, especially when starting or increasing the dose.
Helpful habits:
- Drink regularly through the day instead of chugging a huge amount at once.
- Pay extra attention in hot weather, during exercise, or if you have diarrhea or vomiting.
- Use water-rich foods, soups, and oral electrolyte drinks when normal intake is low.
There is no single mandatory water number for everyone. Needs depend on body size, climate, activity, food intake, and health conditions. If you have heart failure, kidney disease, or a prescribed fluid limit, ask your clinician before intentionally increasing fluids or electrolytes.
Preventing Constipation
Constipation is a common side effect with semaglutide and tirzepatide. Fiber can help, but jumping fiber too fast without enough fluid can make bloating worse.
Try this:
- Increase fiber gradually.
- Pair fiber with fluids.
- Use fruit, vegetables, oats, beans, chia, or psyllium as tolerated.
- Do not dump a big fiber supplement into a day of almost no food and almost no water.
Managing Nausea and Reflux
Stomach side effects are common during dose increases. Retatrutide's Phase 2 trial also reported mostly mild-to-moderate gastrointestinal effects that were dose-related, with fewer issues when people started lower.
Strategies that often help:
- Smaller meals
- Slower eating
- Stopping at early fullness
- Avoiding lying down right after eating
- Limiting very fatty, fried, or spicy meals when nausea or reflux is active
Do Not Rush Dose Increases
Dose escalation exists to improve tolerability. Speeding up because the scale feels slow can raise the chance of nausea, vomiting, dehydration, and other problems.
Stick to the schedule your clinician gave you. If side effects are hard to manage, talk with the prescriber instead of self-adjusting.
Important for retatrutide: Retatrutide is still being studied in clinical trials. It is not an approved everyday medicine like Wegovy or Zepbound. Do not invent your own retatrutide dosing schedule from forums.
Exercise and Strength Training
Weight loss can include fat and muscle. The nutrition advisory emphasizes resistance exercise, enough protein, and overall nutrient intake to support muscle and bone health.
Simple targets if your clinician says it is safe for you:
- Strength training at least two days per week
- Walking or other aerobic activity most days
- Avoid stacking very fast weight loss, extremely low calories, and zero strength work
When to Contact Your Clinician
Get medical help for severe or lasting problems. Contact a clinician urgently for:
- Severe, persistent abdominal pain, especially pain that goes to the back
- Repeated vomiting or inability to keep liquids down
- Fainting, confusion, very little urine, or marked weakness
- Signs of a serious allergic reaction
- Severe abdominal swelling or pain with persistent constipation and vomiting
Product labels for these medicines also discuss risks such as pancreatitis, gallbladder problems, severe gastrointestinal reactions, and kidney injury from fluid loss. Your clinician can explain which risks apply to you.
Semaglutide vs Tirzepatide vs Retatrutide
- Semaglutide: Available as prescription products such as Wegovy and Ozempic for specific labeled uses.
- Tirzepatide: Available as prescription products such as Zepbound and Mounjaro for specific labeled uses.
- Retatrutide: An investigational triple-pathway medicine still in clinical trials. Published Phase 2 obesity data exist, but there is no approved public-use dosing regimen.
For research comparisons of the trial data, see retatrutide vs tirzepatide vs semaglutide: what trials show and retatrutide explained.
Frequently Asked Questions
Do I have to go keto? No.
Should I skip carbs completely? No. Focus on useful carbs and sensible portions.
How much protein do I need? A practical starting point for many adults is about 20 to 30 grams per meal, adjusted with a clinician if needed.
How much water is enough? Drink steadily. Increase attention if you are sick, hot, or active. There is no one-size-fits-all number.
Can I raise my dose early to lose weight faster? Do not self-escalate. Follow the prescribed schedule.
Is this medical advice? No. Use it as education and check decisions with your clinician.
References
- Mozaffarian, D., et al. (2025). Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from ACLM, ASN, OMA, and The Obesity Society. Obesity. Read the advisory
- Wegovy (semaglutide) prescribing information: warnings on gastrointestinal effects, dehydration, and acute kidney injury risk with fluid loss.
- Zepbound (tirzepatide) prescribing information: warnings on gastrointestinal effects, dehydration, and acute kidney injury risk with fluid loss.
- Jastreboff, A.M., et al. (2023). Triple-hormone-receptor agonist retatrutide for obesity: a Phase 2 trial. New England Journal of Medicine. Read the study
- Eli Lilly. Retatrutide clinical development materials describing retatrutide as an investigational triple agonist in ongoing trials.
